Palash Securi. (PALASHSECU)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹90.8 |
| Market Cap | ₹90.83 Cr |
| P/E Ratio | 5.65 |
| ROCE | -2.53% |
| ROE | 2.16% |
| Dividend Yield | 0% |
| Profit Growth | 5.03% |
| Debt/Equity | 0 |
| Sales Growth | 21.94% |
| Promoter Holding | 72.18% |
| 52-Week Range | ₹79.01 — ₹132.7 |
| Sector | Food Products |
| Book Value | ₹36.56 |
Strengths
- Low leverage with debt-to-equity of 0.07 provides financial stability.
- Promoter holding at 72.18% ensures strong insider ownership.
- P/E of 7.47 appears cheap if earnings quality improves (though suspect).
- Positive ROE of 9.76% and reasonable book value of ₹36.56 provide some floor.
- Piotroski F-score of 5/9 is not terrible, indicating some healthy signals.
Concerns
- ROCE is negative at -2.53%, signalling poor core operating performance.
- Sales declined 21.32%, showing shrinking business scale.
- Profit growth of 1000% and quarterly net profit of ₹22 Cr vs ₹10 Cr sales point to likely non-operating or one-time gains.
- No dividend yield, so shareholders get no cash return while waiting.
AI Analysis
At first glance, Palash Securi appears to be a classic value trap. The market cap is just ₹95 Cr and the P/E is 7.47, but I have learned to look behind the multiple. The core business is packaged foods, and here the operating picture is poor. Sales have fallen 21.32%, and ROCE is negative at -2.53%, meaning the company is not earning a satisfactory return on the capital employed in its actual operations. The positive ROE of 9.76% and the staggering 1000% profit growth are suspect—the latest quarter shows net profit of ₹22 Cr against sales of merely ₹10 Cr. That is not a sustainable operating margin; it smells of non-recurring income or accounting noise. As Graham would say, a low P/E is only meaningful if the earnings are real and repeatable. That said, the balance sheet is conservative: debt-to-equity is just 0.07, and the promoter holding is high at 72.18%, which aligns interests. But a P/B of 2.71 for a business earning 9.76% ROE is hardly a bargain. The Piotroski score of 5 out of 9 suggests mediocre financial health. I would not call this a stalwart or a grower. It is a possible turnaround, but only if core operations revive. For now, I stay on the sidelines, waiting for evidence that sales stop shrinking and ROCE turns positive before trusting the reported earnings.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer